Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mestan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|August 10, 1983
Structural properties of myosin from the particulate fraction of human blood plateletsI Peleg, I Kahane, A Eldor, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1970
[A new method of measurement of the coronary output using rubidium 86]J Di Matteo, A Vacheron, D Sabaut, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Skp2 is oncogenic and overexpressed in human cancersM Gstaiger, R Jordan, M Lim, et al.
British Journal of Cancer|May 25, 2006
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
British Journal of Cancer|June 21, 2019
Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
Leukemia|March 1, 1992
Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatinA D Ho, A Klotzbücher, A Gross, et al.
Nature|October 5, 1986
Antiviral effects of recombinant tumour necrosis factor in vitroJ Mestan, W Digel, S Mittnacht, et al.
The Journal of Infectious Diseases|May 1, 1997
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitorsJ K Lazdins, J Mestan, G Goutte, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1975
[Measurement of mean pulmonary pressures and right systolic ventricular pressure by radiocardiography]J Di Matteo, A Vacheron, B Meilhac, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 10, 1983
Structural properties of myosin from the particulate fraction of human blood plateletsI Peleg, I Kahane, A Eldor, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1970
[A new method of measurement of the coronary output using rubidium 86]J Di Matteo, A Vacheron, D Sabaut, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Skp2 is oncogenic and overexpressed in human cancersM Gstaiger, R Jordan, M Lim, et al.
British Journal of Cancer|May 25, 2006
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
British Journal of Cancer|June 21, 2019
Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
Leukemia|March 1, 1992
Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatinA D Ho, A Klotzbücher, A Gross, et al.
Nature|October 5, 1986
Antiviral effects of recombinant tumour necrosis factor in vitroJ Mestan, W Digel, S Mittnacht, et al.
The Journal of Infectious Diseases|May 1, 1997
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitorsJ K Lazdins, J Mestan, G Goutte, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1975
[Measurement of mean pulmonary pressures and right systolic ventricular pressure by radiocardiography]J Di Matteo, A Vacheron, B Meilhac, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
Pageof 3